Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,023 across all filing types
Latest filing 2011-04-01 AGM Information
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
Convoc AGM_ENG.pdf
AGM Information Classification · 98% confidence The document is an official invitation to an Annual General Meeting (AGM) for UCB. It outlines the agenda, proposed resolutions for ordinary and special business (including director appointments, discharge of auditors, and share allocation programs), and instructions for shareholder attendance and proxy voting. This document serves as the formal notice and information statement provided to shareholders prior to the meeting, which falls under the Proxy Solicitation & Information Statement category.
2011-04-01 English
Convoc AGM_FR.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is an official invitation to an Annual General Meeting (Assemblée Générale Ordinaire) for UCB. It outlines the agenda, including the approval of annual accounts, discharge of directors, re-election of board members, and specific proposals regarding share attribution and bond conditions. As it provides the agenda and materials for shareholders to vote on at the upcoming meeting, it is classified as a Proxy Solicitation & Information Statement.
2011-04-01 French
Convoc AGM_NL.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is an official invitation to shareholders for an Annual General Meeting (Gewone Algemene Vergadering). It outlines the agenda, including the approval of annual accounts, discharge of directors, re-election of board members, and specific proposals regarding share plans and bond issuance. As it provides information to shareholders to request their attendance and votes for the upcoming meeting, it falls under the category of Proxy Solicitation & Information Statement.
2011-04-01 Dutch
Convoc EGM_ENG.pdf
AGM Information Classification · 99% confidence The document explicitly calls for shareholders to attend a 'new Extraordinary General Meeting' on April 28, 2011, following a previous meeting that lacked quorum. The text details several 'Proposal of resolution' items concerning amendments to the articles of association (e.g., director term limits, establishing committees, adapting to new shareholder rights laws). It also provides specific instructions for attendance, proxy submission, and share deposit deadlines related to this upcoming meeting. This content is characteristic of materials distributed to solicit votes or provide information ahead of a shareholder meeting, which aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). While it relates to an AGM/EGM, the focus is on the procedural and informational aspects leading up to the vote, rather than the results (DVA) or the meeting presentation itself (AGM-R).
2011-04-01 English
Convoc EGM_FR.pdf
AGM Information Classification · 99% confidence The document explicitly states that a previous Extraordinary General Meeting (Assemblée Générale Extraordinaire) failed to meet quorum and calls for a new one on April 28, 2011. The text details the specific agenda items, which involve proposing modifications to the company's statutes (bylaws) regarding director mandates, establishing a remuneration and nomination committee, and aligning statutes with new shareholder rights laws. This content is characteristic of the official notice and agenda for a shareholder meeting, specifically an Extraordinary General Meeting, which falls under the scope of materials used to solicit votes or provide information prior to the meeting. Since the document details the agenda and proposals for a shareholder meeting, it is best classified as Proxy Solicitation & Information Statement (PSI). It is not the final voting results (DVA), nor is it a general Annual General Meeting (AGM-R) which typically covers standard annual business, although this is an EGM.
2011-04-01 French
Convoc EGM_NL.pdf
AGM Information Classification · 98% confidence The document explicitly calls for a 'nieuwe Buitengewone Algemene Vergadering' (new Extraordinary General Meeting of Shareholders) to be held on April 28, 2011, following a previous meeting that failed to reach quorum. The text details the agenda items, which primarily involve proposed resolutions to amend the company's articles of association (statuten) regarding director mandates, establishing a remuneration and nomination committee, and aligning with new shareholder rights legislation. This content is characteristic of the formal notice and agenda provided for a shareholder meeting, specifically an Extraordinary General Meeting (EGM). While the content relates to governance and potential remuneration changes, the primary purpose and structure of the document is the convocation and agenda for the shareholder meeting itself. This aligns best with the 'AGM Information' category, which covers presentations and materials shared during General Meetings (AGM/EGM).
2011-04-01 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.